Part 7/Chapter 45/17-min read

Thoracic Outlet Syndromes: Neurogenic, Venous, and Arterial

Thoracic outlet syndrome requires careful classification. Neurogenic, venous, and arterial TOS share the scalene, costoclavicular, and pectoralis minor spaces, but they differ in diagnostic certainty, urgency, imaging, treatment sequence, and outcome measure. Neurogenic TOS requires a multi-criterion clinical diagnosis with active exclusion of mimics; venous TOS is an acute effort-thrombosis pathway built around anticoagulation, selected thrombolysis, decompression, and follow-up; arterial TOS is uncommon but dangerous when embolisation, aneurysm, thrombosis, or limb ischemia is present.

Listen to this chapter8 min · AI audio edition · two hostsAI narration

Planning conference: A practical planning-room conversation: anatomy, device or operative choices, surveillance, complications, and decision boundaries.

Choose the hosts

Three thoracic outlet syndromes that share an anatomic compartment

The initial clinical priority in thoracic outlet syndrome is identifying which structure is being injured. Neurogenic TOS, venous TOS or Paget-Schroetter syndrome, and arterial TOS all arise from crowding of structures that pass through the scalene triangle, costoclavicular space, and pectoralis minor region, but they are not three equal flavours of one disease. They differ in presenting symptom, diagnostic certainty, tempo, imaging target, treatment sequence, and the outcome that defines success . A useful consultation therefore begins by naming the variant aloud before any operative plan is discussed.

Neurogenic, venous, and arterial TOS by presentation, first-line imaging, urgency, primary intervention, and outcome metric
  • SVS Tos Reporting 2016
    Clinical stance
    Thoracic outlet syndrome should be classified as neurogenic, venous, or arterial before treatment language is used, because the three variants share an anatomic compartment but differ in presentation, diagnostic certainty, urgency, surgical indication, and the outcome metric that defines success.
    Applies to
    All patients evaluated for suspected thoracic outlet syndrome
    Boundary
    Citation
  • Eans Tos Part1 2022
    Clinical stance
    Neurogenic TOS diagnosis follows a multi-criterion framework — compatible symptoms, compatible examination, functional impact, mimic exclusion, and selected response to scalene block — and is graded as probable or definite rather than confirmed by a single provocative maneuver.
    Applies to
    Patients with suspected neurogenic thoracic outlet syndrome
    Boundary
    Citation
  • Systematic review
    Clinical stance
    Venous TOS and Paget-Schroetter syndrome are best managed as a staged pathway: therapeutic anticoagulation, catheter-directed thrombolysis in suitable candidates, first-rib decompression to remove the mechanical compressive substrate, and surveillance venography with symptom-based follow-up.
    Applies to
    Patients with acute venous TOS or axillosubclavian effort thrombosis (Paget-Schroetter)
    Boundary
    Evidence is observational and meta-analytic; randomized head-to-head comparisons of staged pathway components are not present in the admitted evidence base.
    Citation
  • Arterial Tos Review 2021
    Clinical stance
    Arterial TOS presentations — digital embolisation, subclavian-artery aneurysm with mural thrombus, acute upper-limb ischemia, and exertional arm ischemia, typically with a cervical rib or congenital bony anomaly — demand urgent vascular surgical evaluation and arterial repair, not the conservative neurogenic TOS pathway.
    Applies to
    Patients with arterial TOS or suspected subclavian-artery pathology related to thoracic outlet compression
    Boundary
    Arterial repair (interposition or bypass) is typically paired with decompression of the compressive substrate; specific technique selection depends on lesion and team experience.
    Citation

Neurogenic TOS is the common clinic problem and the least secure diagnostically. The patient usually describes activity-related pain, paraesthesia, heaviness, fatigability, weakness, or loss of overhead tolerance rather than an immediately visible vascular event. Symptoms may localise to the neck, shoulder girdle, chest wall, arm, forearm, or hand, and the examination is often a pattern-recognition exercise rather than a single decisive sign. That uncertainty is why neurogenic TOS is vulnerable to over-diagnosis when every unexplained arm symptom is routed toward first-rib resection. The diagnosis has to be built from compatible symptoms, examination, functional limitation, exclusion of competing diagnoses, and selected adjunctive testing, not from a provocative maneuver alone .

Venous TOS has a different clinical rhythm. It is usually encountered as effort thrombosis of the axillosubclavian vein in a young or active patient who develops sudden arm swelling, cyanosis, heaviness, and sometimes venous collaterals after repetitive or strenuous upper-limb use. Once thrombosis is demonstrated, the diagnostic certainty is higher than in neurogenic TOS and the management becomes time-sensitive. Anticoagulation, consideration of catheter-directed thrombolysis in selected early presenters, and later decompression are linked steps because the thrombus and the compressive substrate both matter .

Arterial TOS is uncommon but has the clearest danger signal. The concern is not chronic discomfort but arterial injury from a cervical rib or other congenital bony anomaly, leading to subclavian-artery stenosis, post-stenotic dilatation or aneurysm, mural thrombus, distal embolisation, thrombosis, exertional arm ischemia, or acute upper-limb ischemia . This patient should not be placed into an elective conservative neurogenic pathway while digital emboli or subclavian aneurysm are being investigated. The shared anatomic corridor must not obscure the variant-specific risk: one syndrome is often a diagnosis of exclusion, one is an effort-thrombosis pathway, and one is a limb-threatening arterial problem.

Neurogenic TOS as a multi-criterion diagnosis with explicit mimic exclusion

Neurogenic TOS is best approached as a structured clinical probability, not as a reflex response to a positive stress test. Current consensus frameworks organise the diagnosis around several converging elements: symptoms compatible with brachial-plexus irritation or compression, a matching examination pattern, functional limitation in work or overhead activity, deliberate exclusion of mimics, and in selected patients a response to scalene block that supports the proposed pain generator . This structure matters because a patient with vague arm pain and a positive provocative maneuver is not the same patient as one with reproducible distribution, functional loss, consistent examination, plausible anatomy, and a negative mimic workup.

The history should identify the task that fails. Many patients describe pain or paraesthesia only after overhead work, repetitive shoulder activity, carrying loads, driving, typing, athletic throwing, or instrument use. Others report nocturnal symptoms, hand clumsiness, or fatigue rather than a simple dermatomal complaint. These features should be mapped against the physical examination: posture and shoulder girdle mechanics, supraclavicular or scalene tenderness, reproduction of symptoms with arm positioning, distal sensory pattern, motor findings, and signs of an alternative peripheral entrapment. Provocative tests may support the pattern, but they cannot carry the diagnosis by themselves because false-positive responses are common in patients with other neck, shoulder, and nerve disorders .

Mimic exclusion is an essential component of the diagnosis. Cervical radiculopathy, especially C7 or C8 disease, can produce pain, paraesthesia, weakness, and scapular symptoms that look like neurogenic TOS. Ulnar nerve entrapment at the elbow can mimic lower-plexus symptoms. Rotator-cuff disease, adhesive capsulitis, and scapulothoracic dysfunction can make overhead activity painful and can secondarily alter posture. Complex regional pain syndrome, fibromyalgia, and other chronic pain syndromes can amplify symptoms and reduce the specificity of examination findings . The clinician should therefore choose targeted tests from the differential rather than ordering a generic battery: cervical-spine imaging when radiculopathy is plausible, electrodiagnostic testing when ulnar neuropathy or another entrapment is suspected, shoulder imaging when local shoulder pathology leads the picture, and neurology or pain input when the pattern is not anatomically coherent.

The scalene block is useful only when the rest of the case has been built carefully. A selected response can help predict that decompression of the scalene and first-rib region may address the symptom generator, but it should not rescue an otherwise unsupported diagnosis. The same caution applies to the language of probable versus definite neurogenic TOS. A probable case can justify rehabilitation, posture and shoulder-girdle work, and longitudinal reassessment; it should not automatically trigger an operation. A definite or high-confidence case, particularly one with substantial functional disability and failed structured conservative care, can support a surgical discussion, but that discussion must still acknowledge that neurogenic TOS outcomes are more heterogeneous than venous or arterial substrate-driven repair .

Imaging selected by the variant being investigated

Imaging in suspected TOS should answer the clinical question raised by the variant. A single default study is attractive for clinic efficiency but unreliable for decision-making, because the target may be bone, brachial plexus, dynamic venous obstruction, acute thrombus, subclavian-artery injury, or a non-TOS mimic. The ACR imaging guidance, the EANS diagnostic consensus, and broader TOS literature all support the same practical principle: select the modality according to the structure at risk and the management decision that will follow .

For suspected neurogenic TOS, early imaging is usually used to define anatomy and exclude competing diagnoses rather than to prove compression. Plain radiography of the cervical spine and thoracic outlet can identify a cervical rib or anomalous bony anatomy that changes pre-test probability and operative planning. MRI of the cervical spine is useful when the symptom pattern suggests radiculopathy, and MRI of the brachial plexus is selected when plexopathy, mass, fibrosis, or another non-TOS process remains in the differential . The result should be interpreted with the examination: an anatomic variant without the right symptoms is not a surgical indication, while a normal static image does not by itself exclude a dynamic clinical syndrome.

TreatmentWhich imaging modality answers which TOS clinical question
  • Patients needing imaging during evaluation for suspected TOS
    Action
    Imaging in suspected TOS should be selected by variant: cervical-spine radiography and brachial-plexus MRI for neurogenic TOS and mimic exclusion, dynamic duplex and venography for venous TOS, and CTA or MRA with provocative positioning for arterial TOS and bony anatomy.
    Decision point
    ACR Tos Imaging 2020
    Boundary
    Citation
  • Patients with suspected neurogenic thoracic outlet syndrome who require mimic workup
    Action
    Cervical radiculopathy, ulnar nerve entrapment at the elbow, rotator-cuff disease, complex regional pain syndrome, and fibromyalgia overlap with the neurogenic TOS picture and must be actively excluded before a neurogenic TOS diagnosis is made.
    Decision point
    Tos Comprehensive Jones 2019
    Boundary
    Mimic exclusion frequently involves cervical-spine MRI, EMG and nerve-conduction studies, shoulder MRI, and neurology input depending on clinical pattern.
    Citation

For venous TOS, the first vascular question is whether there is thrombosis of the axillary or subclavian vein and whether positional compression is present. Duplex ultrasound can identify acute thrombus, loss of compressibility in accessible segments, abnormal flow, and dynamic change with arm positioning, but the subclavian segment can be technically limited by the clavicle and first rib. When intervention is being considered, catheter venography provides treatment planning information and can be combined with thrombolysis, venoplasty, or post-decompression assessment depending on the stage of care . A venous study performed only with the arm at rest may miss the pathophysiology that appears during abduction or strenuous positioning.

For arterial TOS, the imaging question is whether repetitive compression has injured the subclavian artery. CTA or MRA with provocative positioning can demonstrate compression, stenosis, aneurysm, thrombus, distal embolic source, and the relation of the artery to a cervical rib or anomalous first rib . Dynamic duplex can support the evaluation, especially when demonstrating positional waveform change, but cross-sectional imaging is often needed to plan repair and decompression. The report should describe the bony anatomy, arterial wall abnormality, thrombus, distal runoff concern, and whether the finding is positional or fixed.

Imaging selection should start with the suspected variant, followed by the study that will direct the next step. A cervical-spine MRI does not stage effort thrombosis; a resting duplex does not exclude dynamic compression; a CTA without provocative arm positioning may miss intermittent arterial compromise; and a venogram does not explain a patient whose real problem is cervical radiculopathy. Imaging is most valuable when the clinician has already asked which structure is being compressed and what decision the image must support .

Venous effort thrombosis as a staged pathway and arterial danger signals

Venous TOS should be treated as an acute thrombotic and mechanical problem. The classic presentation is sudden swelling, cyanosis, heaviness, or venous distension of the dominant or heavily used arm, often after strenuous overhead activity or repetitive shoulder motion. Once axillosubclavian effort thrombosis is suspected, therapeutic anticoagulation is the immediate step unless contraindicated, because the first obligation is to prevent thrombus propagation and embolic or post-thrombotic consequences while the patient is assessed for definitive management .

Risk FactorsArterial and acute venous TOS findings that mandate urgent vascular evaluation
  • Patients with arterial TOS or suspected subclavian-artery pathology related to thoracic outlet compression
    Action
    Arterial repair (interposition or bypass) is typically paired with decompression of the compressive substrate; specific technique selection depends on lesion and team experience.
    Why it matters
    Arterial TOS presentations — digital embolisation, subclavian-artery aneurysm with mural thrombus, acute upper-limb ischemia, and exertional arm ischemia, typically with a cervical rib or congenital bony anomaly — demand urgent vascular surgical evaluation and arterial repair, not the conservative neurogenic TOS pathway.
    Citation
  • Patients with acute venous TOS or axillosubclavian effort thrombosis (Paget-Schroetter)
    Action
    Evidence is observational and meta-analytic; randomized head-to-head comparisons of staged pathway components are not present in the admitted evidence base.
    Why it matters
    Venous TOS and Paget-Schroetter syndrome are best managed as a staged pathway: therapeutic anticoagulation, catheter-directed thrombolysis in suitable candidates, first-rib decompression to remove the mechanical compressive substrate, and surveillance venography with symptom-based follow-up.
    Citation
  • Patients with acute venous TOS being considered for catheter-directed thrombolysis
    Action
    The 14 day threshold is the commonly cited cutoff in the meta-analytic literature; exact upper bounds vary by center protocol and patient candidacy and should be confirmed against the source.
    Why it matters
    Catheter-directed thrombolysis in venous TOS is most effective when delivered within approximately 14 days of symptom onset, after which the residual thrombus is harder to clear and clinical benefit attenuates.
    Citation

The second question is whether the patient is a candidate for catheter-directed thrombolysis. In suitable patients with acute presentation, acceptable bleeding risk, and functionally important symptoms, thrombolysis is generally most effective when performed early; the commonly cited window is within approximately 14 days of symptom onset, after which thrombus organization makes clearance more difficult and the expected benefit falls . This threshold should be used as a clinical urgency signal rather than as a rigid promise of success. A patient presenting very early with a swollen, cyanotic, high-demand arm is different from one presenting late with established chronic occlusion and collaterals.

The third step is decompression of the thoracic outlet in selected patients, usually by first-rib resection with division of the relevant soft-tissue compressive structures. Thrombolysis can clear clot, and anticoagulation can reduce thrombotic risk, but neither removes the repetitive compression that produced the event. That is why venous TOS treatment is often staged: anticoagulate, restore venous patency when feasible, decompress the costoclavicular space, and then reassess the vein with venography and symptom-based follow-up . The supporting literature is largely observational and aggregate, but the mechanical logic is consistent: leaving the compressive substrate in place after effort thrombosis risks persistent obstruction, recurrent thrombosis, or chronic post-thrombotic symptoms.

Follow-up requires active assessment for recurrent swelling, venous claudication, persistent stenosis, rethrombosis, anticoagulation complications, and whether the patient has returned to the activity that provoked the original event. Post-decompression venography and symptom-guided reassessment help identify patients who need further venous intervention or continued anticoagulation decisions . A good outcome requires durable venous patency, symptom relief, and safe return to function.

Arterial TOS uses a different urgency scale. Digital embolisation, blue or painful fingers, a subclavian-artery aneurysm with mural thrombus, acute upper-limb ischemia, exertional arm ischemia, or a fixed arterial lesion associated with a cervical rib or other bony anomaly should trigger urgent vascular evaluation . These findings imply arterial wall injury, embolic source, or threatened limb perfusion. The management conversation often includes decompression of the compressive anatomy plus arterial reconstruction, such as interposition grafting or bypass, matched to the lesion and the patient. The high-cost mistake is to treat digital emboli or a subclavian aneurysm as though they were part of an elective neurogenic TOS rehabilitation pathway.

Decompression evidence, patient selection, and the honest boundary

The evidence for decompression varies across thoracic outlet syndromes. In venous TOS, decompression follows a demonstrated thrombotic event and a plausible mechanical cause: the axillosubclavian vein has been compressed in the costoclavicular space, thrombosed, and may rethrombose or remain obstructed if the substrate is left untreated. Observational series and meta-analytic summaries support decompression as part of the staged pathway after anticoagulation and selected thrombolysis, with follow-up focused on venous patency and recurrent symptoms . The treatment is still individualised, but the substrate is visible and the clinical endpoint is concrete.

In arterial TOS, the rationale is also mechanical but the endpoint is arterial protection. The patient may have a cervical rib or congenital bony anomaly causing repetitive subclavian-artery trauma, aneurysm, thrombus, distal embolisation, or occlusion. Decompression alone is often insufficient when the artery has already been damaged; arterial repair and removal of the compressive substrate are considered together, with the reconstruction matched to the lesion . The clinical boundary is therefore clearer than in neurogenic disease: embolisation, aneurysm, and ischemia are not quality-of-life complaints alone but vascular injury states.

Neurogenic TOS surgical-benefit boundary and the role of patient selection
  • Practical takeaway
    Patients being considered for thoracic outlet decompression across the three TOS variants
    What is known
    Surgical decompression evidence is variant-dependent and weakest in neurogenic TOS, where randomized data are lacking and patient selection plus structured rehabilitation drive outcomes more than the choice of operative approach.
    Uncertainty / boundary
    Center experience and operator volume are load-bearing in any reported outcome; approach selection (supraclavicular, transaxillary, paraclavicular, robotic) is matched to variant, anatomy, and team competence rather than identified as a single best approach.
    Citation
  • Practical takeaway
    Patients with suspected neurogenic thoracic outlet syndrome
    What is known
    Neurogenic TOS diagnosis follows a multi-criterion framework — compatible symptoms, compatible examination, functional impact, mimic exclusion, and selected response to scalene block — and is graded as probable or definite rather than confirmed by a single provocative maneuver.
    Uncertainty / boundary
    Eans Tos Part1 2022
    Citation

Neurogenic TOS is where the operation is most debated. The proposed target is brachial-plexus irritation from compression, traction, or soft-tissue crowding, but there is no universally decisive diagnostic test and the outcome is usually symptom and function improvement rather than restoration of a measurable lumen. Current consensus and surgical literature describe decompression benefit in selected patients, but the results are heterogeneous, randomized comparative evidence is limited, and outcomes depend heavily on diagnostic discipline, exclusion of mimics, rehabilitation, and center experience . A patient with poorly localized pain, untreated cervical radiculopathy, or diffuse pain amplification is unlikely to benefit from the same discussion as a patient with a coherent neurogenic pattern, marked functional limitation, appropriate adjunctive support, and failed structured non-operative care.

The choice of surgical approach depends on anatomy and team experience. Supraclavicular, transaxillary, paraclavicular, and robotic approaches have all been described, and each can expose different structures well while creating different risks and learning-curve demands . For venous TOS, the approach must allow adequate first-rib and costoclavicular decompression around the vein. For arterial TOS, it must accommodate both decompression and arterial reconstruction. For neurogenic TOS, it must permit safe decompression of the brachial plexus region while respecting that the operation cannot compensate for a weak diagnosis.

The patient conversation should therefore be variant-specific. In venous TOS, decompression is discussed as part of a staged strategy to restore and preserve venous outflow. In arterial TOS, it is part of preventing further embolic or ischemic injury. In neurogenic TOS, it is an option for carefully selected patients after structured assessment, mimic exclusion, and usually a course of rehabilitation. Careful patient selection is essential. Decompression can be valuable when the variant, anatomy, symptoms, and treatment goal align, but the wrong label leads to the wrong operation and the wrong outcome measure .

References

  1. 1.
    ACR Appropriateness Criteria Thoracic Outlet Syndrome. 2020.
    PubMed-indexed articleClinical practice guideline2020

    ACR Appropriateness Criteria Thoracic Outlet Syndrome. 2020. doi:10.1016/j.jacr.2020.01.029.

  2. 2.
    Arterial thoracic outlet syndrome: clinical presentation and management review. 2021.
    PubMed-indexed articleReview2021

    Arterial thoracic outlet syndrome: clinical presentation and management review. 2021. doi:10.1016/j.avsg.2020.10.077.

  3. 3.
    EANS consensus on thoracic outlet syndrome diagnosis (Part 1). 2022.
    PubMed-indexed articleClinical practice guideline2022

    EANS consensus on thoracic outlet syndrome diagnosis (Part 1). 2022. doi:10.1007/s00701-022-05291-x.

  4. 4.
    International Thoracic Outlet Syndrome Society consensus on neurogenic TOS. 2024.
    DOI publisher routeClinical practice guideline2024

    International Thoracic Outlet Syndrome Society consensus on neurogenic TOS. 2024. doi:10.1016/j.jvscit.2024.101542.

  5. 5.
    Outcomes after Paget-Schroetter syndrome treatment: systematic review and meta-analysis. 2023.
    DOI publisher routeMeta-analysis / systematic review2023

    Outcomes after Paget-Schroetter syndrome treatment: systematic review and meta-analysis. 2023. doi:10.1016/j.ejvs.2023.08.065.

  6. 6.
    Surgical approaches for thoracic outlet syndrome. 2023.
    PubMed-indexed articleReview2023

    Surgical approaches for thoracic outlet syndrome. 2023. doi:10.1016/j.thorsurg.2023.04.002.

  7. 7.
    Reporting standards of the Society for Vascular Surgery for thoracic outlet syndrome. 2016.
    DOI publisher route2016

    Reporting standards of the Society for Vascular Surgery for thoracic outlet syndrome. 2016. doi:10.1016/j.jvs.2016.04.039.

  8. 8.
    Comprehensive review of thoracic outlet syndrome. 2019.
    PubMed-indexed articleReview2019

    Comprehensive review of thoracic outlet syndrome. 2019. doi:10.1016/j.jvs.2019.04.501.

  9. 9.
    Catheter-directed thrombolysis for venous thoracic outlet syndrome. 2021.
    PubMed-indexed articleRegistry / cohort2021

    Catheter-directed thrombolysis for venous thoracic outlet syndrome. 2021. doi:10.1016/j.jvsv.2021.01.013.

  10. 10.
    Postoperative follow-up after venous thoracic outlet syndrome decompression. 2018.
    PubMed-indexed articleRegistry / cohort2018

    Postoperative follow-up after venous thoracic outlet syndrome decompression. 2018. doi:10.1016/j.jvs.2017.12.069.

  11. 11.
    Thoracic Outlet Syndrome Part II: Consensus on the Management of Neurogenic Thoracic Outlet Syndrome by the European Association of Neurosurgical Societies' Section of Peripheral Nerve Surgery.
    PubMed-indexed articleClinical practice guideline2023

    Thoracic Outlet Syndrome Part II: Consensus on the Management of Neurogenic Thoracic Outlet Syndrome by the European Association of Neurosurgical Societies' Section of Peripheral Nerve Surgery. doi:10.1227/neu.0000000000002232.

Educational use only

AI assists this editorial workflow. Published updates are human-reviewed before publication.

Not intended to diagnose, monitor, predict, prognose, treat, or alleviate disease.

Verify clinically relevant information against primary sources and current guidelines.